Brenda Medina on Muck Rack

Brenda Medina

Verified
Florencia, New York
As seen in: The International Consortium of Investigative Journalists (ICIJ), MSN, El País, Infobae, The Toronto Star, U.S. News and World Report, Miami Herald, Mother Jones, ProPublica, Orlando Sentinel, South Florida Sun Sentinel and
Journalist/Periodista. Now @ICIJorg, previously @propublica, @elnuevoherald, @MiamiHerald, always missing el Caribe ☀️🏝
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Brenda

Contact Brenda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Senator questions Merck over patent strategy for blockbuster cancer drug Keytruda

|
By Brenda Medina Verified
| The International Consortium of Investigative Journalists (ICIJ)
A U.S. senator is pressing pharmaceutical giant Merck over its patenting and pricing practices for the blockbuster cancer drug Keytruda, escalating congressional scrutiny of industry strategies that can delay lower-cost rivals from reaching the market. Sen.
Open in Who Shared Issue with article?

Law enforcement, banks warn of money laundering gaps in major US crypto bill

|
By Brenda Medina Verified
| The International Consortium of Investigative Journalists (ICIJ)
Law enforcement associations, anti-corruption advocates and a major banking group are warning that a new bill aimed at regulating the United States’ cryptocurrency industry could leave big gaps in safeguards against dirty money in digital currencies that have already become a financial vehicle for organized crime. Known as the Clarity Act, the bill seeks to bring cryptocurrency under a single legal framework on the national level, ending years of the industry operating in gray areas.
Open in Who Shared View Duplicates (2) Issue with article?

Lowering doses of cancer drugs could slash global health spending by $30B, new research shows

|
By Brenda Medina Verified
| The International Consortium of Investigative Journalists (ICIJ)
New studies presented at the American Society of Clinical Oncology’s annual conference suggest that reducing the dosage of anti-cancer medicines — including Keytruda, the world’s bestselling drug — could drastically cut global health costs by billions of dollars a year and improve access for patients. The U.S. Food and Drug Administration approved the initial dosage of Keytruda in 2014 based on a patient’s body weight, at 2 milligrams per kilogram.
Open in Who Shared Issue with article?
See all 528 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified